Investor Relations

Press Releases


Press Releases

Date Title  
December 1, 2021 Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19
November 9, 2021 Fulgent Genetics Reports Third Quarter Financial Results
November 9, 2021 Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences
November 8, 2021 Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection
November 4, 2021 Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform
November 1, 2021 Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting® 2021
October 27, 2021 Fulgent Genetics Launches At-Home Neutralizing Antibody Test for COVID-19
October 25, 2021 Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021
September 23, 2021 Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program
August 9, 2021 Fulgent Genetics Reports Second Quarter Financial Results
August 9, 2021 Fulgent Genetics Announces Acquisition of CSI Laboratories
August 9, 2021 Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests
July 26, 2021 Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
May 10, 2021 Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech
May 6, 2021 Fulgent Genetics Reports Record First Quarter Financial Results
May 6, 2021 Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
April 16, 2021 Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021
March 15, 2021 Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus
March 5, 2021 Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference
March 4, 2021 Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results
February 18, 2021 Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
January 6, 2021 Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference